Assessing the risk of recurrent thrombosis and the Vienna Prediction Model

2015-06-05

James Douketis

See also

Management tips for use of the new oral anticoagulants Prof. James Douketis, from McMaster University, Canada, addresses real-world "what if" scenarios for managing patients on NOACs, such as how to choose the right NOAC, determine if a patient needs a procedure or surgery, understand safety of concomitant drugs, and prescribe off-label use of NOACs.
An association between novel oral anticoagulants, acute coronary syndromes, and the risk of myocardial infarction Is there an association between novel oral anticoagulants, acute coronary syndromes, and the risk of myocardial infarction?
Management of acute deep vein thrombosis and pulmonary embolism Prof. Jeffrey Weitz, from McMaster University, Canada, discusses the burden of disease, home and hospital treatment, role of NOACs, and duration of anticoagulation. The lecture concludes with practical take-home messages.
The optimal approach to anticoagulant treatment in patients with a high bleeding risk What is the optimal approach to anticoagulant treatment in patients with a high bleeding risk? How should we estimate the bleeding risk and adjust anticoagulant treatment to the bleeding risk?

We would love to hear from you

Comments, mistakes, suggestions?